Protalix BioTherapeutics, Inc. (PLX)
NYSEAMERICAN: PLX · Real-Time Price · USD
1.720
+0.140 (8.86%)
At close: Sep 9, 2025, 4:00 PM
1.730
+0.010 (0.58%)
After-hours: Sep 9, 2025, 8:00 PM EDT
Protalix BioTherapeutics Employees
Protalix BioTherapeutics had 213 employees as of December 31, 2024. The number of employees increased by 5 or 2.40% compared to the previous year.
Employees
213
Change (1Y)
5
Growth (1Y)
2.40%
Revenue / Employee
$290,836
Profits / Employee
$29,460
Market Cap
137.14M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 213 | 5 | 2.40% |
| Dec 31, 2023 | 208 | 11 | 5.58% |
| Dec 31, 2022 | 197 | -9 | -4.37% |
| Dec 31, 2021 | 206 | -1 | -0.48% |
| Dec 31, 2020 | 207 | 11 | 5.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PLX News
- 7 days ago - Protalix BioTherapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference - PRNewsWire
- 15 days ago - Protalix: Speculative Buy On Promising Plant-Cell Platform And Elfabrio Ramp - Seeking Alpha
- 26 days ago - Protalix BioTherapeutics, Inc. (PLX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 26 days ago - Protalix BioTherapeutics Reports Second Quarter 2025 Financial and Business Results - PRNewsWire
- 4 weeks ago - Protalix BioTherapeutics to Announce Second Quarter 2025 Financial and Business Results on August 14, 2025 - PRNewsWire
- 7 weeks ago - Protalix BioTherapeutics Appoints Gilad Mamlok as its New Senior Vice President and Chief Financial Officer - PRNewsWire
- 2 months ago - Protalix BioTherapeutics Added to Russell 3000® and 2000 Indexes® - PRNewsWire
- 4 months ago - Protalix BioTherapeutics to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference at Nasdaq NYC - PRNewsWire